GlassScriptPhysician profile
Beth A Harpenau
NPI 1528418662
$2,654.83
in general payments reported to CMS, 2019-2025
24 companies · $576 in 2025
The $576 reported for 2025 was more than what 96% of Advanced Practice Midwife providers received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $211 · 2022: $448 · 2023: $1,223 · 2024: $196 · 2025: $576.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,339 · Honoraria: $656.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,338.79 |
| Honoraria | $656.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Women'S Health, INC. | $683.08 | 2023 | Myrisk |
| Hologic Sales and Service, LLC | $370.85 | 2022-2025 | Novasure, Myosure Tissue Removal Device, Acessa Provu System |
| Abbvie INC. | $339.98 | 2021-2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $216.76 | 2022-2025 | |
| Astellas Pharma US INC | $191.68 | 2023-2025 | Veozah |
| Mayne Pharma Commercial LLC | $168.39 | 2022-2025 | |
| Exact Sciences Corporation | $97.86 | 2025 | The Cologuard Plus Collection Kit |
| Pfizer INC. | $75.17 | 2023-2025 | |
| Coopersurgical, INC. | $69.94 | 2021-2024 | Paragard T 380a |
| Sumitomo Pharma America, INC. | $55.96 | 2023-2025 | Myfembree |
| Organon LLC | $48.61 | 2022-2024 | |
| Evofem Biosciences, INC. | $47.10 | 2021-2023 | Phexxi |
| Aspira Women'S Health INC | $42.70 | 2024 | Ova1 |
| Mylan Pharmaceuticals INC. | $38.48 | 2022 | |
| Becton, Dickinson and Company | $28.16 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $27.88 | 2025 | Zurzuvae |
| Sage Therapeutics, LLC | $27.18 | 2023 | |
| Therapeuticsmd, INC. | $24.67 | 2022 | |
| Solventum Corporation | $23.72 | 2025 | |
| Daiichi Sankyo INC. | $18.98 | 2022 | |
| Smith+Nephew, INC. | $16.56 | 2024 | Renasys Touch, Pico 7, Pico 14 |
| Exeltis, USA INC. | $14.96 | 2025 | Slynd |
| Optumhealth Care Solutions, LLC | $13.68 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Scynexis, INC. | $12.48 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beth Harpenau listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.